Vigil Neuroscience, Inc., (VIGL) Social Stream



Vigil Neuroscience, Inc., (VIGL): $6.70

-0.96 (-12.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VIGL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 397

in industry

Vigil Neuroscience Inc (VIGL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Vigil Neuroscience Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-29 4 $24 $17 $21 $7.17 192.89%
NA 4 $NA $NA $NA $7.17 NA%

Over the past 56 days, VIGL's average upside potential has been 147.02%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-01 4 24 17 21 13.45 56.13%
2022-03-25 4 24 17 21 7.38 184.55%
2022-03-26 4 24 17 21 7.38 184.55%
2022-03-29 4 24 17 21 7.99 162.83%

VIGL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Vigil Neuroscience Inc's number of analysts covering the stock is higher than 38.16% of them.
  • Vigil Neuroscience Inc's average analyst price target is greater than 77.51% of stocks in the micro market cap category.
  • In terms of how Vigil Neuroscience Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 73.38% of that group.
  • In the context of Healthcare stocks, Vigil Neuroscience Inc's upside potential (average analyst target price relative to current price) is greater than 61.94% of them.

Stocks similar to Vigil Neuroscience Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TCRX, TCON, and TARA.

Is VIGL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.381 seconds.